Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
Guiyang Longmaster Information & Technology (300288)
- 9.98
- +0.17+1.73%
Market Closed Jun 5 15:00 CST
3.37BMarket Cap-2495.00P/E (TTM)
10.10High9.66Low54.99KlotVolume9.81Open9.81Prev Close54.46MTurnover2.14%Turnover Ratio356.43P/E (Static)337.94MShares17.3752wk High3.12P/B2.56BFloat Cap9.6652wk Low11.77Limit Up256.57MShs Float101.34Historical High7.85Limit Down4.49%Range %5.75Historical Low0.02Dividend TTM9.90Avg Price22.89KlotAsk0.15%Div Yield TTM100Lot Size31.45KlotBid
Guiyang Longmaster Information & Technology (300288) News
Langma Information: 2025 Annual Report
Langma Information: First Quarter Report for 2026
Langma Information: Summary of the 2025 Annual Report
Langma Information (300288.SZ): Currently, there are no plans for restructuring or mergers and acquisitions.
Gelonghui, March 6th ┃ Langma Information (300288.SZ) stated on the interactive platform that the company currently has no plans for restructuring or mergers and acquisitions. If related matters arise in the future, the company will strictly adhere to the relevant regulations on information disclosure and promptly fulfill its obligations for information disclosure.
Langma Information (300288.SZ) forecasts a net profit of RMB 10 million to RMB 14.5 million for the fiscal year 2025.
Gelonghui, January 30th, Report: Langma Information (300288.SZ) announced an estimated net profit attributable to shareholders of the listed company of RMB 10 million to RMB 14.5 million for 2025, reversing a loss from the previous year. In 2024, due to the company's provision for impairment of goodwill amounting to RMB 566.4816 million formed by the acquisition of 100% equity in its wholly-owned subsidiary, Guangzhou Qisheng Information Technology Co., Ltd. (hereinafter referred to as 'Qisheng Information'), the consolidated net profit attributable to shareholders of the listed company incurred a loss of RMB 512.0997 million. During this reporting period, revenue from Qisheng Information showed
Langma Information: 2025 Annual Performance Forecast
Langma Information (300288.SZ): Currently, no research and development work related to brain-computer interface technology has been carried out.
Gelonghui, January 7th: Langma Information (300288.SZ) stated on the interactive platform that the company has not currently engaged in the research and development of brain-computer interface-related technologies.
Langma Information (300288.SZ): The company has no plans to transfer control.
Gelonghui, December 19th ┃ Langma Information (300288.SZ) stated on the investor interaction platform that the company has no plans to transfer control rights.
Langma Information: Report for the third quarter of 2025
Langma Information (300288.SZ) reported a net loss of RMB 928,500 in the third quarter.
Gelonghui, October 29th丨Langma Information (300288.SZ) announced its Q3 2025 earnings report. The company generated RMB 72.5269 million in revenue for the third quarter, representing a year-on-year decrease of 36.46%; it incurred a net loss of RMB 0.9285 million. For the first three quarters, the company achieved revenue of RMB 224 million, reflecting a year-on-year decline of 24.75%, with net profit reaching RMB 13.507 million, down 67.04% year-on-year.
The Director of the National Bureau of Statistics: Actively identify innovative enterprises in the digital economy and accelerate the cultivation of a unified national data market.
Liu Liehong, Secretary of the Party Leadership Group and Director of the National Bureau of Statistics, held a symposium yesterday (9th) to gather opinions and suggestions on promoting the high-quality development of data trading institutions and accelerating the cultivation of a nationwide integrated data market. He pointed out that the development of the data market is still in its infancy and requires the collective wisdom and strength of all parties to collaboratively address and resolve issues, thereby significantly promoting the high-quality development of data trading institutions and hastening the establishment of a national integrated data market. He emphasized the need to promptly research and formulate policy documents to promote the high-quality development of data trading institutions and cultivate a national integrated data market, while continuously constructing a robust foundational data system referred to as the 'four pillars and eight columns.' On the same day, Liu Liehong presided over...
Express News | The National Bureau of Statistics solicits opinions from private entrepreneurs in the digital economy.
Langma Information: 2025 Semi-Annual Report Summary
Langma Information: 2025 Semi-Annual Report
Express News | Langma Information: Net profit in the first half of 2025 decreased by 39.97% year-on-year.
Huawei, Ant Group, and others are vying to enter the AI Medical field | Focus
① Ruijin Hospital and Huawei have launched the open-source pathology large model "RuiPath," while Ant Group has introduced the AI health application "AQ." According to forecasts, China's AI Medical market size is expected to increase from 8.8 billion yuan in 2023 to 315.7 billion yuan by 2033. ② The lack of medical data and high costs of digital construction continue to affect the application of AI in the medical field.
Guiyang Longmaster Information & Technology: In the first quarter of 2025, R&D expenses decreased by 32.55% year-on-year.
On May 6th, Gelonghui reported that Guiyang Longmaster Information & Technology stated on the interactive platform that R&D expenses mainly include leasing costs, depreciation costs, custody costs, labor costs, etc. The primary reason for the year-on-year decrease in R&D expenses in the first quarter of 2025 was that the company focused its resources on the research and development of medical AI, resulting in the optimization of its original business and personnel, leading to a 32.55% decrease in R&D expenses in the first quarter of 2025 compared to the first quarter of 2024.
Express News | DeepSeek released the Prover-V2 model, with a parameter count reaching 671 billion.
The pharmaceutical digital intelligence sector collectively rose, with Meinian Onehealth Healthcare Holdings increasing by over 3%. Seven departments issued documents encouraging the implementation of AI-enabled pilot projects across the entire Industry C
On April 25th, Gelonghui reported that the pharmaceutical sector in the A-share market experienced a collective increase, with Hangzhou Century rising over 13%, B-Soft Co.,Ltd. up more than 7%, Guiyang Longmaster Information & Technology and Winning Health Technology Group both rising over 5%, Shanghai Runda Medical Technology, Guangdong Biolight Meditech, and Improve Medical Instruments up over 4%, Dian Diagnostics Group, Avcon Information Technology, Meinian Onehealth Healthcare Holdings, DHC Software, Wonders Information, and Jiahe Meikang all increasing by over 3%. In terms of news, seven departments issued the "Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)" proposing the deepening of AI empowerment applications. Support relevant units to establish innovative platforms for large medical models, and collaboratively carry out research and development and regulation of large medical model technological products.
Express News | The Concept of AI medical services was active at the beginning of the market, and Thalys Medical Technology Group Corporation hit the trading limit.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm